CompletedPhase 2NCT00003518
Paclitaxel Plus Gemcitabine in Treating Patients With Refractory Metastatic Germ Cell Tumors
Studying Germ cell tumor of testis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Eastern Cooperative Oncology Group
- Principal Investigator
- Lawrence H. Einhorn, MDIndiana University Melvin and Bren Simon Cancer Center
- Intervention
- gemcitabine hydrochloride(drug)
- Enrollment
- 44 enrolled
- Eligibility
- 15-120 years · All sexes
- Timeline
- 1999
Study locations (19)
- CCOP - Colorado Cancer Research Program, Inc., Denver, Colorado, United States
- Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois, United States
- Veterans Affairs Medical Center - Chicago (Lakeside), Chicago, Illinois, United States
- CCOP - Carle Cancer Center, Urbana, Illinois, United States
- Indiana University Cancer Center, Indianapolis, Indiana, United States
- Veterans Affairs Medical Center - Indianapolis (Roudebush), Indianapolis, Indiana, United States
- CCOP - Cedar Rapids Oncology Project, Cedar Rapids, Iowa, United States
- CCOP - Ochsner, New Orleans, Louisiana, United States
- Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
- CCOP - Kalamazoo, Kalamazoo, Michigan, United States
- CCOP - Metro-Minnesota, Saint Louis Park, Minnesota, United States
- Hackensack University Medical Center, Hackensack, New Jersey, United States
- Kimball Medical Center, Lakewood, New Jersey, United States
- Morristown Memorial Hospital, Morristown, New Jersey, United States
- University of Rochester Cancer Center, Rochester, New York, United States
- +4 more locations on ClinicalTrials.gov
Collaborators
National Cancer Institute (NCI)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00003518 on ClinicalTrials.govOther trials for Germ cell tumor of testis
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07498959Primary RPLND Versus Systemic Chemotherapy in Good-prognosis Metastatic Testicular CancerSahlgrenska University Hospital
- RECRUITINGPHASE1NCT07218913Testing the Addition of Pedmark to Cisplatin Chemotherapy for Reducing Drug-Induced Ear Damage in Men With Stage II-III Metastatic Testicular Germ Cell TumorsCity of Hope Medical Center
- RECRUITINGPHASE2NCT06866964A Single-arm, Phase II Clinical Trial of ASPIRin to prEvent Venous Thromboembolism in Patients With Advanced Germ Cell Tumors Receiving ChemotherapyWake Forest University Health Sciences
- RECRUITINGPHASE2NCT06932458A Clinical Trial of Primary Retroperitoneal Lymph Node Dissection in Patients With Testicular Seminoma With Limited Retroperitoneal MetastasesWestern University, Canada
- RECRUITINGNANCT05588700Impact of a Physical Activity Program to Reduce Long-term Cancer-related Fatigue in Metastatic Testicular Germ Cell Tumor PatientsCentre Leon Berard
- RECRUITINGNCT06309745THERApy De-escalation for TESTicular CancerQueen Mary University of London
- RECRUITINGPHASE1NCT06276491Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid TumorsXencor, Inc.
- RECRUITINGNANCT06133543Robot-assisted ICG-guided Sentinel Node Biopsy in Testicular CancerHeinrich-Heine University, Duesseldorf